Chemical Structure (Revonto 01)
Revonto Injection, Powder, Lyophilized, For Solution
Product Images NDC 78670-003
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Revonto (NDC 78670-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Uswm, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (20 mg Vial Carton)
Revonto® is an injectable medication used in the treatment of malignant hyperthermia. Available in six non-returnable vials, each containing 20 mg of dantrolene sodium, it is for intravenous use only. The vials must be protected from direct light and used within an hour of reconstitution with 60 mL of sterile water. It is recommended not to use any other acid-based solution with Revonto®. Refer to the package insert for complete preparation instructions. The product should be stored at a controlled room temperature of 20°C-25°C (68°F-77°F) and prolonged exposure to light must be avoided. Revonto® is a registered trademark of USWL, LLC.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
